[Glucocorticosteroids in the treatment of acute neurosensory hearing loss. The current state of the problem. Part 2]

Vestn Otorinolaringol. 2022;87(5):70-74. doi: 10.17116/otorino20228705170.
[Article in Russian]

Abstract

Modern literature data are presented on the choice of a drug for hormonal therapy in acute neurosensory hearing loss of various origins, the doses used for systemic therapy, the features and methods of intratympanic administration of glucocorticosteroids, and the evaluation of the effectiveness of treatment with this group of drugs.

Представлены современные данные литературы о выборе препарата для гормональной терапии при острой нейросенсорной тугоухости различного генеза, используемых дозах для системной терапии, особенностях и способах интратимпанального введения глюкокортикостероидов и оценке эффективности лечения препаратами этой группы.

Keywords: acute sensorineural hearing loss; glucocorticosteroids; treatment.

Publication types

  • English Abstract

MeSH terms

  • Administration, Oral
  • Dexamethasone
  • Hearing Loss, Sensorineural* / diagnosis
  • Hearing Loss, Sensorineural* / drug therapy
  • Hearing Loss, Sudden* / diagnosis
  • Hearing Loss, Sudden* / drug therapy
  • Humans
  • Treatment Outcome

Substances

  • Dexamethasone